Physician profile

Craig Ono

Orthopaedic Surgery · Kingman, AZ

NPI 1457329955

$814.47

in general payments reported to CMS, 2019-2025

7 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$341.41

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Nuvasive, INC. $423.02 2019-2023 Xlif, Reline, Pulse
Smith+Nephew, INC. $122.97 2023-2024 Rf20000, Na, N/A
Orthopediatrics Corp. $117.64 2019
Biomarin Pharmaceutical INC. $68.00 2020
Ipsen Biopharmaceuticals, INC $35.83 2022-2023 Dysport
Globus Medical, INC. $24.75 2023 Excelsiusgps Robotic Navigation System
Kyowa Kirin, INC. $22.26 2024 Crysvita

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Craig Ono

$814.47

in general payments reported 2019-2025

Years
2019-2024
Top company
Nuvasive, INC.

https://glasscript.com/doctor/746492/craig-ono

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.